Coelho Rogerio Vivaldi has an estimated net worth of $4.55 Million. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., Spark Therapeutics, Inc., Sigilon Therapeutics, Inc., Minerva Neurosciences, Inc., Bioverativ Inc., and Viatris Inc.

2016 was Coelho Rogerio Vivaldi's most active year for acquiring shares with 8 total transactions. Coelho Rogerio Vivaldi's most active month to acquire stocks was the month of January. 2016 was Coelho Rogerio Vivaldi's most active year for disposing of shares, totalling 11 transactions. Coelho Rogerio Vivaldi's most active month to dispose stocks was the month of February. 2022 saw Coelho Rogerio Vivaldi paying a total of $1,552,400.00 for 698,750 shares, this is the most they've acquired in one year. In 2015 Coelho Rogerio Vivaldi cashed out on 142,333 shares for a total of $3,158,400.00, their largest year based on trade value.